Integral Diagnostics
(ASX) IDX
Integral Diagnostics Financials at a Glance
Market Cap
$845.55M
Revenue (TTM)
$1.26B
Net Income (TTM)
$19.69M
EPS (TTM)
$0.04
P/E Ratio
60.21
Dividend
$0.07
Beta (Volatility)
0.01 (Low)
Dividend
$0.07
Beta (Volatility)
0.01 (Low)
Price
$2.27
Volume
1,060,783
Open
$2.28
Price
$2.27
Volume
1,060,783
Open
$2.28
Previous Close
$2.27
Daily Range
$2.24 - $2.29
52-Week Range
$2.18 - $3.07
Dividend
$0.07
Beta (Volatility)
0.01 (Low)
Price
$2.27
Volume
1,060,783
Open
$2.28
Previous Close
$2.27
Daily Range
$2.24 - $2.29
52-Week Range
$2.18 - $3.07
IDX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Integral Diagnostics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
2,779
CEO
Ian Kadish, MBA, PhD
Headquarters
Melbourne, VIC 3000, AU
IDX Financials
Key Financial Metrics (TTM)
Gross Margin
22%
Operating Margin
9%
Net Income Margin
2%
Return on Equity
2%
Return on Capital
5%
Return on Assets
1%
Earnings Yield
1.66%
Dividend Yield
0.03%
Payout Ratio
1.55%
Stock Overview
Market Cap
$845.55M
Shares Outstanding
372.49M
Volume
1.06M
Short Interest
0.00%
Avg. Volume
881.65K
Financials (TTM)
Gross Profit
$599.09M
Operating Income
$57.53M
EBITDA
$87.70M
Operating Cash Flow
$73.77M
Capital Expenditure
$59.76M
Free Cash Flow
$14.01M
Cash & ST Invst.
$52.10M
Total Debt
$585.01M
Integral Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$393.48M
+70.2%
Gross Profit
$84.82M
+65.8%
Gross Margin
21.56%
N/A
Market Cap
$845.55M
N/A
Market Cap/Employee
$427.69K
N/A
Employees
1,977
N/A
Net Income
$8.96M
+113.4%
EBITDA
$70.21M
+323.3%
Quarterly Fundamentals
Net Cash
$807.42M
-135.1%
Accounts Receivable
$27.75M
-22.0%
Inventory
$2.95M
+59.1%
Long Term Debt
$821.83M
+139.2%
Short Term Debt
$19.71M
+10.2%
Return on Assets
0.99%
N/A
Return on Invested Capital
5.46%
N/A
Free Cash Flow
$7.98M
+131.9%
Operating Cash Flow
$32.84M
+115.9%